News

Latest news

7th January 2019

DBJ Signs Contract with Newton Biocapital I Pricaf Privee SA, a Japanese-European Venture Capital Fund for Early Stage Pharmaceuticals

Read more
21st December 2018

EPICS Therapeutics to Acquire Ogeda former assets, Adding Drug Discovery & Development Capabilities

Read more
19th November 2018

UK NICE recommends use of the alfapump® for the treatment of refractory ascites caused by cirrhosis under special arrangements

Read more
25th October 2018

Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises €8.5 million from leading Belgian investors including Newton Biocapital, PMV and SFPI-FPIM as well as existing shareholders

Read more
24th October 2018

Acticor Biotech raises €15.3 M in a Series B financing

Read more
19th June 2018

ChromaCure S.A., a spin-off from the Université libre de Bruxelles (ULB),is launched with €17m committed equity investment to develop enhanced cancer therapies

Read more
5th June 2018

Synergia raises €8.1 million in Series A

Read more
25th April 2018

Acticor Biotech announces that the European Medicines Agency clears the route for a Phase II of its ACT017 product in stroke

Read more